Evogene (Israel) Price Patterns
| EVGN Stock | ILA 315.00 2.70 0.86% |
Momentum 35
Sell Extended
Oversold | Overbought |
Using Evogene hype-based prediction, you can estimate the value of Evogene from the perspective of Evogene response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Evogene to buy its stock at a price that has no basis in reality. In that case, they are not buying Evogene because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Evogene after-hype prediction price | ILA 315.0 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Evogene |
Evogene After-Hype Price Density Analysis
As far as predicting the price of Evogene at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Evogene or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Evogene, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Evogene Estimiated After-Hype Price Volatility
In the context of predicting Evogene's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Evogene's historical news coverage. Evogene's after-hype downside and upside margins for the prediction period are 311.33 and 318.67, respectively. We have considered Evogene's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Evogene is very steady at this time. Analysis and calculation of next after-hype price of Evogene is based on 3 months time horizon.
Evogene Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Evogene is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Evogene backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Evogene, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.31 | 3.67 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
315.00 | 315.00 | 0.00 |
|
Evogene Hype Timeline
Evogene is currently traded for 315.00on Tel Aviv Stock Exchange of Israel. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Evogene is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at -0.31%. %. The volatility of related hype on Evogene is about 0.0%, with the expected price after the next announcement by competition of 315.00. The company has price-to-book (P/B) ratio of 0.93. Some equities with similar Price to Book (P/B) outperform the market in the long run. Evogene recorded a loss per share of 0.72. The entity had not issued any dividends in recent years. The firm had 10:1 split on the 28th of July 2024. Assuming the 90 days trading horizon the next forecasted press release will be in a few days. Check out Evogene Basic Forecasting Models to cross-verify your projections. For information on how to trade Evogene Stock refer to our How to Trade Evogene Stock guide.Evogene Related Hype Analysis
Having access to credible news sources related to Evogene's direct competition is more important than ever and may enhance your ability to predict Evogene's future price movements. Getting to know how Evogene's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Evogene may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| XTLB | XTL Biopharmaceuticals | 0.00 | 0 per month | 0.00 | (0.08) | 7.41 | (7.69) | 75.03 | |
| BLRX | BioLine RX | 0.00 | 0 per month | 0.00 | (0.10) | 6.67 | (6.25) | 18.01 | |
| CANF | Can Fite Biopharma | 0.00 | 0 per month | 0.00 | (0.13) | 3.33 | (4.91) | 76.00 | |
| CBI | Clal Biotechnology Industries | 0.00 | 0 per month | 0.00 | (0.05) | 5.33 | (5.07) | 17.86 | |
| TKUN | Tikun Olam Cannbit | 0.00 | 0 per month | 0.00 | (0.09) | 6.07 | (6.23) | 41.70 | |
| BOLT | BioLight Life Sciences | 0.00 | 0 per month | 0.00 | (0.07) | 6.31 | (5.62) | 17.87 | |
| IDNT | Identi Healthcare | 0.00 | 0 per month | 0.00 | (0.05) | 7.92 | (5.27) | 19.73 | |
| ALMD | Allmed Solutions | 0.00 | 0 per month | 2.09 | 0.06 | 5.30 | (4.08) | 11.82 | |
| PLNT | Plantarc Bio | 0.00 | 0 per month | 1.53 | 0.07 | 5.18 | (2.85) | 16.68 | |
| PPBT | Purple Biotech | 0.00 | 0 per month | 4.92 | 0.01 | 9.09 | (8.33) | 59.74 |
Evogene Additional Predictive Modules
Most predictive techniques to examine Evogene price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Evogene using various technical indicators. When you analyze Evogene charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Evogene Predictive Indicators
The successful prediction of Evogene stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Evogene, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Evogene based on analysis of Evogene hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Evogene's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Evogene's related companies.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Complementary Tools for Evogene Stock analysis
When running Evogene's price analysis, check to measure Evogene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evogene is operating at the current time. Most of Evogene's value examination focuses on studying past and present price action to predict the probability of Evogene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evogene's price. Additionally, you may evaluate how the addition of Evogene to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |